Difference between revisions of "Part:BBa K2933013"
(→Exploration of expression condition) |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 7: | Line 7: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | + | SHD is a type of subclass B metal beta-lactamases. The beta lactamases of the SHD family can hydrolyze almost all available beta lactam antibiotics (except aztreonam) clinically, including the broad-spectrum antibiotic carbapenems. Because of the extensive substrate profile of this enzyme, the clinical strains carrying it become a great threat to human life and health.<br> | |
<!-- --> | <!-- --> | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K2933013 SequenceAndFeatures</partinfo> | <partinfo>BBa_K2933013 SequenceAndFeatures</partinfo> | ||
| − | |||
| − | |||
===Molecular cloning=== | ===Molecular cloning=== | ||
| Line 42: | Line 40: | ||
'''Figure 2.''' The result of SDS-page.<br> | '''Figure 2.''' The result of SDS-page.<br> | ||
</p> | </p> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
==References== | ==References== | ||
Latest revision as of 10:26, 21 September 2019
subclass B1 metallo-beta-lactamase SHD, codon optimized in E. coli
This part encodes a protein called SHD, which is a metallo-beta-lactamase of subclass B1.
Usage and Biology
SHD is a type of subclass B metal beta-lactamases. The beta lactamases of the SHD family can hydrolyze almost all available beta lactam antibiotics (except aztreonam) clinically, including the broad-spectrum antibiotic carbapenems. Because of the extensive substrate profile of this enzyme, the clinical strains carrying it become a great threat to human life and health.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Molecular cloning
First, we used the vector pGEX-6p-1 to construct our expression plasmid. And then we converted the plasmid constructed to E. coli DH5α to expand the plasmid largely.
Figure 1. Left: The PCR result of SHD. Right: The verification results by enzyme digestion.
After verification, it was determined that the construction is successful. We converted the plasmid to E. coli BL21(DE3) for expression and purification.
Expression and purification
Pre-expression:
The bacteria were cultured in 5mL LB liquid medium with ampicillin(100 μg/mL final concentration) in 37℃ overnight.
Massive expressing:
After taking samples, we transfered them into 1L LB medium and add antibiotic to 100 μg/mL final concentration. Grow them up in 37°C shaking incubator. Grow until an OD 600 nm of 0.8 to 1.2 (roughly 3-4 hours). Induce the culture to express protein by adding 1 mM IPTG (isopropylthiogalactoside, MW 238 g/mol). Put the liter flasks in 16°C shaking incubator for 16h.
Affinity Chromatography:
We used the GST Agarose to purify the target protein. The GST Agarose can combine specifically with the GST tag fused with target protein.
- First, wash the column with GST-binding buffer for 10 minutes to balance the GST column.
- Second, add the protein solution to the column, let it flow naturally and bind to the column.
- Third, add GST-Washing buffer several times and let it flow. Take 10μl of wash solution and test with Coomassie Brilliant Blue. Stop washing when it doesn’t turn blue.
- Forth, add 400μL Prescission Protease (1mg/mL) to the agarose. Digest for 16 hours in 4℃.
- Fifth, add GST-Elution buffer several times. Check as above. Collect the eluted proteins for further operation.
Figure 2. The result of SDS-page.